HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Previous close
$8.27
Day range
$8.04 - $8.58
Year range
$5.11 - $10.67
Market cap
1.09B USD
Avg Volume
1.19M
P/E ratio
29.27
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 62.46M | 24.18% |
Operating expense | 24.77M | -43.15% |
Net income | 23.34M | 317.17% |
Net profit margin | 37.37 | 274.87% |
Earnings per share | 0.16 | 328.57% |
EBITDA | 28.24M | 1,738.77% |
Effective tax rate | 4.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 312.59M | -2.12% |
Total assets | 504.85M | -2.28% |
Total liabilities | 154.66M | -1.59% |
Total equity | 350.19M | — |
Shares outstanding | 135.10M | — |
Price to book | 3.26 | — |
Return on assets | 11.08% | — |
Return on capital | 13.21% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 23.34M | 317.17% |
Cash from operations | 1.30M | 106.99% |
Cash from investing | 31.03M | -36.97% |
Cash from financing | -49.34M | -227.80% |
Net change in cash | -17.00M | -209.12% |
Free cash flow | -19.47M | -384.13% |
About
Founded
2012
Headquarters
Website
Employees
130
